Related Articles
April 18, 2024 | NEJM
Image Challenge from the New England Journal of Medicine — April 18, 2024
Agency for Healthcare Research and Quality (AHRQ)
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
YouTube
¿Sabía usted que aproximadamente la mitad de los 3 millones de estadounidenses que viven con glaucoma no saben que tienen esta enfermedad de los ojos?…
Fundamentals of Lower Bowel Webinar | Event | Royal College of Nursing
This free webinar is being led by the RCN Bladder and Bowel forum committee to support member engagement and to provide an educational session on…
The PCF Women in Science Forum: Empowering Female Researchers Through Networking and Mentorship – Veda Giri, Ayesha Shafi, & Claire Fletcher
Andrea Miyahira hosts a discussion with Veda Giri, Ayesha Shafi, and Claire Fletcher, members of the PCF Women in Science Forum Organizing Committee. The forum…
T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
This cohort study assesses the increase in second primary malignant neoplasms and T-cell malignant neoplasm cases associated with chimeric antigen receptor–T cells.
AI tool helps predicts patient responses to cancer drugs
An AI tool called PERCEPTION developed by NCI researchers could one day be used to help more precisely match patients with effective cancer drugs.
Younger Patients With HER2+ Breast Cancer May Benefit from Surgery First
Those aged 18 to 40 years with invasive, HER2-positive breast cancer showed a survival benefit from upfront surgery over neoadjuvant chemotherapy.
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
This cross-sectional study evaluates the rate of detection of cutaneous phosphorylated α-synuclein by skin biopsy in individuals with and without synucleinopathy.
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
This cross-sectional study evaluates the rate of detection of cutaneous phosphorylated α-synuclein by skin biopsy in individuals with and without synucleinopathy.